Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMISSeD: Prophylactic Radiotherapy for Minimally Symptomatic Spinal Disease
NCT05534321Phase 2Recruiting
- Sponsor
- Baptist Health South Florida
- Start
- Aug 2022
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Baptist Health South Florida. Primary endpoint: Skeletal-Related Events at 1 year. Started Aug 2022; status: recruiting.
Beyond the preview
Go deeper on NCT05534321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05534321.